Abstract
Objectives To investigate factors associated with suicidal ideation around the time of dementia diagnosis. We hypothesised that relatively preserved cognition, co-occurring physical and psychiatric disorders, functional impairments and dementia diagnosis subtype would be associated with higher risk of suicidal ideation.
Design Cross-sectional study using routinely collected electronic mental healthcare records.
Setting National Health Service secondary mental healthcare services in South London, United Kingdom, which serve a population of over 1.36 million residents.
Participants Patients who received a diagnosis of dementia (Alzheimer’s, vascular, mixed Alzheimer’s/vascular or dementia with Lewy bodies) between 1/1/2007-30/6/2016. 11,787 people with dementia were identified during the observation period.
Measurements A natural language processing algorithm was used to identify recorded clinician statements about suicidal ideation around the time of dementia diagnosis.
Sociodemographic and clinical characteristics were also measured around the time of diagnosis. We compared people diagnosed with non-Alzheimer’s dementia to those with Alzheimer’s and used statistical models to adjust for putative confounders.
Results 4.8% of patients identified with dementia had recorded suicidal ideation. Recorded suicidal ideation was almost twice as common in dementia with Lewy bodies compared to other dementia diagnoses studied. After adjusting for sociodemographic and clinical factors, dementia with Lewy bodies, physical illnesses or disability and neuropsychiatric symptoms were significantly associated with suicidal ideation. Mini-Mental State Examination score at diagnosis was not associated with suicidal ideation.
Conclusions Although completed suicide is rare, suicidal ideation is present in sufficient proportions of people with dementia to justify treatment of potentially modifiable risk factors within dementia care pathways.
Competing Interest Statement
R. Stewart has received funding from Janssen, GSK and Takeda outside the submitted work. Other authors have nothing to disclose.
Funding Statement
C. Mueller and R. Stewart are part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, which also supports the development and maintenance of the Biomedical Research Centre Case Register. The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR or the Department of Health and Social Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
CRIS has received ethical approval as an anonymized data resource (Oxford Research Ethics Committee C, reference 18/SC/0372)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data accessed by CRIS remain within a National Health Service firewall and governance is provided by a patient-led oversight committee. Subject to these conditions, data access is encouraged and those interested should contact R.Stewart (robert.stewart@kcl.ac.uk), CRIS academic lead.